Cross-border converter
CAE Rev 4 21100 → CNAE-2025 equivalent (Spain)
Portugal's national activity classification (CAE Rev 4) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent CNAE-2025 subclass(es) used in Spain.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21100
Fabricação de produtos farmacêuticos de base
Compreende a fabricação de produtos de origem natural ou sintética, obtidos por processo químico ou biológico, para uso farmacêutico tais como: ácidos salicílicos e os acetilsalicílicos; sulfamidas ou sulfonamidas; açúcares quimicamente puros; vitaminas e provitaminas; hormonas e esteróides; heteróxidos; alcalóides vegetais, naturais e sintéticos; antibióticos; glândulas, extratos de glândulas ou de outros órgãos ou das suas secreções; toxinas, culturas de microrganismos e produtos semelhantes.
21.10
Fabricación de productos farmacéuticos de base
About this conversion
CAE Rev 4 is the activity classification used in Portugal. CNAE-2025 is the equivalent system in Spain. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "CAE Rev 4 21100 to CNAE-2025" and stays in sync with our monthly Market Intelligence sync.